Leishmaniasis is a cluster of diseases caused by protozoa in the genus Leishmania. There
are three basic clinical forms: cutaneous, mucocutaneous, and visceral leishmaniasis. The …

Iran has invariably been under the growing public health threat of cutaneous leishmaniasis
(CL), a significant barrier to local development that hinders the prevention and control efforts …

The Syrian refugee crisis has precipitated a catastrophic outbreak of Old World cutaneous
leishmaniasis now affecting hundreds of thousands of people living in refugee camps or …

Abstract Treatment options for cutaneous leishmaniasis in the United States are problematic
because the available products are either investigational, toxic, and/or of questionable …

The evolution of drug-resistance in pathogens is a major global health threat. Elucidating the
molecular basis of pathogen drug-resistance has been the focus of many studies but rarely …

Background: The aim of present study was to evaluate antileishmanial effects of Lavandula
angustifolia (L. angustifolia) and Rosmarinus officinalis (R. officinalis) medicinal plants …

The aim of this study was to assess the cytotoxic effects of various concentrations of
miltefosine on Leishmania major (MRHO/IR/75/ER) and L. tropica (MHOM/IR/02/Mash10) …

Abstract Background Pentavalent antimonials (Sb 5) and miltefosine are the first-line drugs
for treating cutaneous leishmaniasis in Colombia; however, toxicity and treatment duration …

Background: Miltefosine is the first recognized oral treatment for leishmaniasis. It was first
registered, in 2002, for Indian visceral leishmaniasis, and was reviewed by the present …

Introduction The efficacy of thermotherapy for the treatment of cutaneous leishmaniasis
presents diverse results with low statistical power. Objective To evaluate the efficacy of …